# A Prospective Single-Arm Study（NCLDR）

> **NCT07028918** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 35 (estimated)

## Conditions studied

- Oral Squamous Cell Carcinoma (OSCC)

## Interventions

- **RADIATION:** Low dose radiotherapy regimen
- **DRUG:** New adjuvant immunotherapy regimen
- **PROCEDURE:** Surgical treatment
- **DRUG:** Postoperative adjuvant therapy plan
- **RADIATION:** Radical radiotherapy plan

## Key facts

- **NCT ID:** NCT07028918
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-30
- **Primary completion:** 2026-08-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07028918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07028918, "A Prospective Single-Arm Study（NCLDR）". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07028918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*